TTUHSC Center for Tropical Medicine and Infectious Diseases
HomeTropical Medicine

Center for Tropical Medicine and Infectious Diseases

Mission Left Column Images


The mission of the Center for Tropical Medicine and infectious Diseases (CTMID) is to contribute to the improvement of health worldwide through the pursuit of excellence in research, and advanced training of MS/PhD-graduate students and MD-fellows in infectious diseases and tropical medicine of public health importance. We will strive toward making new discoveries that will translate into the development of sensitive and specific products for the diagnosis, prevention and treatment of important diseases.


Infectious diseases caused by bacteria, viruses, fungi and parasites are the leading causes of mortality, morbidity, and social and economic hardship for hundreds of millions of people worldwide. Infectious diseases are responsible for 17 million deaths each year, which represents one third of the annual mortality worldwide. Infectious diseases are directly responsible for 43% of deaths in developing countries, compared to 1% in industrialized countries.

At present more than 3 billion people are afflicted with major parasitic diseases. Among the "top ten" world health problems are: infection of 2.5 billion people with various species of roundworms, 300 million with flatworms, and 1.5 billion with unicellular parasites. It is estimated that these parasites account for more than 3.5 million deaths annually. These infections primarily affect poor populations living in tropical and subtropical climates, with children being the most vulnerable to infection. The collaborative effort at CTMID is directed toward developing diagnostic tools, vaccines and drugs against neglected tropical diseases (Schistosomiasis, Leishmaniasis, Trypanosomiasis and Strongyloidiasis). Another parasitic disease understudy at CTMID, Trichomoniasis is an important sexually transmitted infection, and is estimated that 250 million new cases of Trichomoniasis occur around the world with 9 million new cases in the United States every year.

CTMID investigators are employing innovative ways to study bacterial pathogenesis; biofilm disease; mechanisms of systemic fungal infections; exploring new diagnostic tools, therapies, and epidemiology of influenza; and developing new tools to diagnose and treat community acquired pneumonia in elderly.